Is Bipolar Disorder Really a Diet Problem?
What this video covers
On The Dr. Hyman Show, Dr. Mark Hyman interviews Dr. Iain Campbell, a neuroscientist and metabolic psychiatry researcher at the University of Edinburgh who himself lives with bipolar disorder type 2. They argue that bipolar is better understood as a disorder of metabolism, circadian rhythm, and brain energy than as a simple neurotransmitter imbalance, and they walk through Campbell’s personal recovery on a ketogenic diet and the pilot research it inspired. Hyman frames the conversation as evidence that psychiatry’s symptom-label model is failing, pointing to his own functional-medicine work and his 2009 book The UltraMind Solution.
Key points
- Campbell recounts his own history: signed as a music producer to Universal Music at 21 and working for film composer Harry Gregson-Williams, he describes two-month periods of catatonic depression and first-time suicidal ideation despite medications, and says a ketogenic diet left him feeling clear, stable, and “not depressed, not manic” for the first time.
- Campbell argues bipolar disorder is at root a metabolic and circadian disorder, citing Emil Kraepelin’s 1921 observations of metabolic disturbance, sleep disruption, and seasonal symptom swings in manic-depressive patients, with mania peaking around the spring and autumn equinoxes and depression around the winter solstice.
- Campbell describes the Edinburgh pilot study he ran — funded by Jan and David Baszucki, whose son Matt reached remission from bipolar disorder on a ketogenic diet with Dr. Chris Palmer after more than 30 failed treatments — in which 20 bipolar patients on a ketogenic diet for six to eight weeks showed reductions of roughly 11–13% in brain glutamate on MR spectroscopy, a marker he notes also tracks response to anti-seizure drugs such as lamotrigine.
- Campbell and Hyman discuss insulin resistance and “fuel partitioning” as a shared mechanism: Campbell argues the brain can be in an energy crisis amid abundant sugar because cellular machinery for using fuel is broken, and Hyman claims fewer than 1% of diagnostic tests in America measure insulin.
- Campbell says the Metabolic Psychiatry Hub at Edinburgh won roughly £4 million from the UK Medical Research Council, with Baszucki co-funding, for work on genetics, population health data, clinical trials, and patient experience, and he points to a roughly $3 million ketogenic-diet trial being launched at Mayo Clinic.
- Campbell cautions that the evidence is still pilot-stage — “I’m not going out saying everyone with psychiatric conditions should just do a ketogenic diet” — and says large randomized controlled trials are needed, while Hyman argues a six-to-eight-week therapeutic trial of ketogenic eating with basic supplements carries “pretty little downside” for most people.
- Hyman closes by arguing that recovery from conditions such as schizophrenia, autism, and bipolar disorder is possible under a root-cause model, and both men direct listeners to resources including the Metabolic Psychiatry Hub and Metabolic Mind.